Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 08/19/05 → 08/18/07 |
Funding
- Immunomedics Incorporated: $2,500.00
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial of Epratuzumab in Patients with Acute Severe SLE Flares Excluding the Renal or Neurologic Systems and/or A Phase III, Randomized, Double-Blind, Placebo-C
- Perl, Andras (PI)
- Neupane, Hom (CoPI)
- Phillips, Paul (CoPI)
Project: Research